The call "Test and Demonstration of Multimodal Data Approaches for Personalised Medicine (“MultiPMData2026”)" has been launched under the European Partnership for Personalised Medicine (EP PerMed). This call aims to test innovative solutions in personalised medicine in real-world settings to address the needs in managing multimorbidity (the co-existence of multiple chronic diseases). Projects are expected to focus on the management of patients with at least two chronic diseases.

📅 Call Timeline

• Call Opening: October 1, 2025
• Phase 1 International Application Deadline: January 12, 2026 (14:00, CET)
• Phase 1 National Application Deadline: January 16, 2026 (23:59, TLT)
• Phase 1 National E-signature Deadline: January 21, 2026 (23:59, TLT)
• Phase 2 International Application Deadline: April 27, 2026 (14:00, CEST)
• Project Start: December 2026 (Expected)

✅ Eligibility

• Projects must be submitted by international consortia that include at least three partners from at least three different EU member or Associated Countries participating in the call.
• The consortium must include at least one private entity (SME or industry) and one clinical partner.
• From Turkey, higher education institutions, training and research hospitals, public institutions and organizations, and capital companies established in Turkey (private organizations) can apply.

📂 Support Scope and Duration

• The project duration can be a maximum of 36 months.
• Project proposals must have reached a Technology Readiness Level (TRL) of at least 3.
• Turkish partners in successful projects will be funded under the TÜBİTAK 1071 Program.

💶 Funding Opportunities

• The maximum funding per project is €220,000 (excluding institutional overhead and project incentive bonus).
• Higher education institutions/Training and research hospitals/Public institutions:
• €125,000 if they are the coordinator.
• €100,000 if they are a partner.
• Private Organizations: €220,000
• Funding rates are 100% for higher education institutions, training and research hospitals, and public institutions; 60% for large-scale private organizations, and 75% for SMEs.

📌 Useful Links

• EP PerMed Project Page
• International Application System
• National Application System